A woman has filed a lawsuit against the makers of breast cancer chemotherapy drug, Taxotere, after she suffered from permanent hair loss after chemotherapy.

Plaintiff Patsy B. brought forth her lawsuit against Sanofi-Aventis alleging the company engaged in various behaviors constituting wrongful conduct.

Patsy states she underwent chemotherapy treatment with Taxotere for her breast cancer in March 2006.

Her lawsuit says “neither Plaintiff nor her treating healthcare providers were aware of or by Defendants that disfiguring permanent alopecia can occur following treatment with Taxotere.”

Not only did Patsy suffer from physically disfiguring permanent alopecia, she and other women who experience permanent hair loss after chemotherapy suffer a great deal mentally and economically.

“There were already products on the market at least as effective as Taxotere that did not subject users to the same risk of permanent alopecia, but users of Taxotere were not presented with the opportunity to make an informed choice as to whether the benefits of Taxotere were worth its associated risks,” Patsy’s lawsuit states.

Taxotere is a drug used to treat a number of different types of cancers and is a common treatment for breast cancer. It belongs to a family of drugs referred to as Taxanes.

Patsy has brought forth a number of counts against the makers of Taxotere including product liability for negligence, failure to warn, fraudulent misrepresentation, among others.

Patsy is seeking relief in terms of actual damages, economic damages, medical expenses, non-economic damages including pain and suffering, punitive damages, pre-and post-judgment interest, attorneys’ fees and costs and any additional relief as provided by the Court.

Hair Loss after Chemotherapy

Women expect that they will lose their hair following chemotherapy treatment. They understand it is a part of the process when undertaking such a treatment regimen.

Hair is lost when chemotherapy is initiated because the cancer-treating drug affects the most rapidly-dividing cells in the body. Hair follicles have some of the most rapidly-dividing cells, and thus hair growth is affected.

Typically, a few months after chemotherapy treatment has ended, women began growing back their hair. For women taking Taxotere, however, some never grow back their hair, and many say this was a side effect of the drug about which they were never informed.

Often, women like Patsy state they would have chosen a different chemotherapy drug to treat their cancer had they known that permanent hair loss after chemotherapy with Taxotere was a possibility.

Filing a Lawsuit Following Permanent Hair Loss after Chemotherapy

If you or a loved one has suffered from permanent hair loss after chemotherapy treatment with Taxotere, you may be eligible to take legal action against the manufacturer to recover damages resulting from your injury.

A Taxotere attorney can review your case at no charge and discuss your legal options if you are eligible.

The Taxotere Permanent Hair Loss after Chemotherapy Lawsuit is Case No. 3:16-cv-09106 in the U.S. District Court for the District of New Jersey.